Report cover image

Organ On A Chip Market

Published Jul 21, 2025
Length 120 Pages
SKU # CMI20302683

Description

The Global organ-on-a-chip market is estimated to be valued at USD 155.3 Mn in 2025 and is expected to reach USD 1,211.1 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 34.1% from 2025 to 2032. The global organ-on-a-chip market has been gaining significant traction in the past few years owing to the growing demand for alternative methods for drug screening and toxicity testing. organ-on-a-chip devices aim to mimic the physiological responses of human organs by replicating their complex microenvironment using microfabrication and microfluidic technologies. They incorporate living cells on a chip lined with microchannels and are capable of modelling organ-level functions and responses. Such devices are being seen as crucial tools for developing safe and effective drugs in a cost-effective manner while reducing dependence on animal testing. With technological advancements, the organ-on-a-chip technology is expected witness wider adoption across various industries in the coming years.

Market Dynamics

The global organ-on-a-chip market is primarily driven by the rising drug development costs and limited success of new drug entities. Organ-on-a-chips provide human-body-on-a-chip platforms for testing drugs and chemical compounds, thus helping drug makers reduce failure rates and curb R&D expenditure. Moreover, stringent regulations regarding safety and efficacy of drugs along with growing emphasis on the 3Rs (Replacement, Reduction, and Refinement) in animal testing is positively influencing the adoption of organ-chip technology. However, the high costs associated with the development of organ-on-a-chip devices and lack of standardized procedures for validation of test results are some of the factors hindering the market growth. Meanwhile, growing funding from private and government bodies for organ chip research is creating new opportunities for market players.

Key Features of the Study
  • This report provides in-depth analysis of the global organ-on-a-chip market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global organ-on-a-chip market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Emulate, Inc., Mimetas, Organovo Holdings, Inc., Roche, AstraZeneca, Pfizer, Harvard Bioscience, Inc., CN Bio Innovations, AxoSim, Synlogic, Inc., Alcyomics Ltd., 3D Biotek, Vascularized Organs, Inc., InSphero AG, Hesperos Inc, NETRI, and Obatala Sciences, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global organ-on-a-chip market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global organ-on-a-chip market.
Market Segmentation
  • Products & Service Insights (Revenue, USD Mn, 2020 - 2032)
  • Products
  • Instruments
  • Devices
  • Heart-on-Chip
  • Lung-on-Chip
  • Liver-on-Chip
  • Kidney-on-Chip
  • Brain-on-Chip
  • Intestine-on-Chip
  • Others
  • Services
  • Application Insights (Revenue, USD Mn, 2020 - 2032)
  • Toxicology Testing
  • Disease Modelling/Physiological model development
  • Drug discovery
  • Stem cell research
  • Tissue regeneration and regenerative medicines
  • End User Insights (Revenue, USD Mn, 2020 - 2032)
  • Pharmaceutical and Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations
  • Others
  • Regional Insights (Revenue, USD Mn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Key Players Insights
  • Emulate, Inc.
  • Mimetas
  • Organovo Holdings, Inc.
  • Roche
  • AstraZeneca
  • Pfizer
  • Harvard Bioscience, Inc.
  • CN Bio Innovations
  • AxoSim
  • Synlogic, Inc.
  • Alcyomics Ltd.
  • 3D Biotek
  • Vascularized Organs, Inc.
  • InSphero AG
  • Hesperos Inc
  • NETRI
  • Obatala Sciences, Inc.

Table of Contents

120 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Global Organ-on-a-Chip Market, By Products & Service
Global Organ-on-a-Chip Market, By Application
Global Organ-on-a-Chip Market, By End User
Global Organ-on-a-Chip Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
Industry Trends
4. Global Organ-on-a-Chip Market, By Products & Service, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Products
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2031, (USD Mn)
Instruments
Devices
Heart-on-Chip
Lung-on-Chip
Liver-on-Chip
Kidney-on-Chip
Brain-on-Chip
Intestine-on-Chip
Others
Services
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2031, (USD Mn)
5. Global Organ-on-a-Chip Market, By Application, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Toxicology Testing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2031, (USD Mn)
Disease Modelling/Physiological model development
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2031, (USD Mn)
Drug discovery
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2031, (USD Mn)
Stem cell research
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2031, (USD Mn)
Tissue regeneration and regenerative medicines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2031, (USD Mn)
6. Global Organ-on-a-Chip Market, By End User, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Pharmaceutical and Biotechnology Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2031, (USD Mn)
Academic & Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2031, (USD Mn)
Contract Research Organizations
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2031, (USD Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2031, (USD Mn)
7. Global Organ-on-a-Chip Market, By Region, 2020-2032, Value (USD Mn)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032 Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
Regional Trends
North America
Introduction
Market Size and Forecast, By Products & Service, 2020-2032, Value (USD Mn)
Market Size and Forecast, By Application, 2020-2032, Value (USD Mn)
Market Size and Forecast, By End User, 2020-2032, Value (USD Mn)
Market Size and Forecast, By Country, 2020-2032, Value (USD Mn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, By Products & Service, 2020-2032, Value (USD Mn)
Market Size and Forecast, By Application, 2020-2032, Value (USD Mn)
Market Size and Forecast, By End User, 2020-2032, Value (USD Mn)
Market Size and Forecast, By Country, 2020-2032, Value (USD Mn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Introduction
Market Size and Forecast, By Products & Service, 2020-2032, Value (USD Mn)
Market Size and Forecast, By Application, 2020-2032, Value (USD Mn)
Market Size and Forecast, By End User, 2020-2032, Value (USD Mn)
Market Size and Forecast, By Country, 2020-2032, Value (USD Mn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Products & Service, 2020-2032, Value (USD Mn)
Market Size and Forecast, By Application, 2020-2032, Value (USD Mn)
Market Size and Forecast, By End User, 2020-2032, Value (USD Mn)
Market Size and Forecast, By Country, 2020-2032, Value (USD Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, By Products & Service, 2020-2032, Value (USD Mn)
Market Size and Forecast, By Application, 2020-2032, Value (USD Mn)
Market Size and Forecast, By End User, 2020-2032, Value (USD Mn)
Market Size and Forecast, By Country, 2020-2032, Value (USD Mn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, By Products & Service, 2020-2032, Value (USD Mn)
Market Size and Forecast, By Application, 2020-2032, Value (USD Mn)
Market Size and Forecast, By End User, 2020-2032, Value (USD Mn)
Market Size and Forecast, By Country/Region, 2020-2032, Value (USD Mn)
South Africa
North Africa
Central Africa
8. Competitive Landscape
Emulate, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Mimetas
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Organovo Holdings, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Roche
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
AstraZeneca
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Harvard Bioscience, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
CN Bio Innovations
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
AxoSim
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Synlogic, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Alcyomics Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
3D Biotek
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Vascularized Organs, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
InSphero AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Hesperos Inc
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
NETRI
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Obatala Sciences, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
9. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
10. References and Research Methodology
References
Research Methodology
About us
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.